Increased conviction in Patient Opportunity’s lead manager and supporting cast warrants a People Pillar upgrade to Above Average from Average, while its Process Pillar remains Average.
Patient Opportunity Trust Class I LMNOX
- NAV / 1-Day Return $62.02 / −0.06 %
- Fund Size $2.1B
- Adjusted Expense Ratio 0.930%
- Net Expense Ratio 1.390%
- Fee Level: Distribution Above Average
- Share Class Type Institutional
- Morningstar Category Mid-Cap Value
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $1M
- Investment Status Open
- TTM Yield 0.13%
- Turnover Ratio 27%
Morningstar’s Analysis LMNOX
Will LMNOX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Royalty Pharma PLC Class A | 6.33 | 140M | Healthcare |
Citigroup Inc | 6.32 | 140M | Financial Services |
Alphabet Inc Class A | 6.05 | 134M | Communication Services |
UnitedHealth Group Inc | 5.63 | 125M | Healthcare |
Amazon.com Inc | 5.11 | 113M | Consumer Cyclical |
NVIDIA Corp | 4.52 | 100M | Technology |
CVS Health Corp | 4.09 | 91M | Healthcare |
QXO Inc | 4.06 | 90M | Industrials |
Norwegian Cruise Line Holdings Ltd | 3.81 | 84M | Consumer Cyclical |
Precigen Warrant Restricted | 3.80 | 84M | — |